Skip to main content

Hillsdale Investment Management Inc.

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1368465 Toronto, A6

Position in AMRX

as of Mar 31, 2026 · filed May 4, 2026
Position Value
$9,243,929
+$240,864 QoQ
Shares Held
743,679
+4.1% QoQ
Ownership
0.233%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
15 quarters on record
Voting authority Sole 96.2752746816839.ToString("F0")% Shared 0.ToString("F0")% None 3.7247253183161013.ToString("F0")%

Common Shares in AMRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Hillsdale Investment Management Inc. holds $35,500,367 across 9 Drug Manufacturers - Specialty & Generic names. AMRX ranks #1 (26.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AMRX
Amneal Pharmaceuticals, Inc.
This page
743,679 $9,243,929

All Filings in AMRX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $9,243,929 743,679
2025-12-31 $9,003,065 714,529
2025-09-30 $7,167,450 716,029
2025-06-30 $6,472 800
2025-03-31 $6,285 750
2024-03-31 $4,240,295 699,719
2023-12-31 $3,548,636 584,619
2023-09-30 $184,071 43,619
2022-09-30 $1,740,665 861,716
2022-06-30 $2,740,256 861,716
2022-03-31 $3,593,355 861,716
2021-12-31 $4,166,896 869,916
2021-09-30 $4,659,235 872,516
2021-06-30 $4,028,497 786,816
2021-03-31 $4,113,376 611,200